Literature DB >> 21653832

Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation.

Keigo Nishida1, Satoru Yamasaki, Aiko Hasegawa, Akihiro Iwamatsu, Haruhiko Koseki, Toshio Hirano.   

Abstract

Mast cells are major players in allergic responses. IgE-dependent activation through FcεR leads to degranulation and cytokine production, both of which require Gab2. To clarify how the signals diverge at Gab2, we established Gab2 knock-in mice that express Gab2 mutated at either the PI3K or SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) binding sites. Examination of these mutants showed that both binding sites were required for the degranulation and anaphylaxis response but not for cytokine production or contact hypersensitivity. Furthermore, the PI3K, but not the SHP2, binding site was important for granule translocation during degranulation. We also identified a small GTPase, ADP-ribosylation factor (ARF)1, as the downstream target of PI3K that regulates granule translocation. FcεRI stimulation induced ARF1 activation, and this response was dependent on Fyn and the PI3K binding site of Gab2. ARF1 activity was required for FcεRI-mediated granule translocation. These data indicated that Fyn/Gab2/PI3K/ARF1-mediated signaling is specifically involved in granule translocation and the anaphylaxis response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653832     DOI: 10.4049/jimmunol.1100360

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Mediators released during human anaphylaxis.

Authors:  Shelley F Stone; Simon G A Brown
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

2.  Genetic Predictors of Susceptibility to Dermatophytoses.

Authors:  Susan M Abdel-Rahman
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

3.  Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.

Authors:  Xiaocui Zhang; Geneviève Lavoie; Antoine Méant; Léo Aubert; Marie Cargnello; André Haman; Trang Hoang; Philippe P Roux
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

4.  Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search.

Authors:  Susan M Abdel-Rahman; Barry L Preuett
Journal:  J Dermatol Sci       Date:  2012-05-27       Impact factor: 4.563

5.  How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov Arbeeva; Alexander Kulminski; Irina Kulminskaya; Igor Akushevich; Svetlana V Ukraintseva
Journal:  N Am Actuar J       Date:  2016-06-22

6.  The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.

Authors:  Timothy D Bryson; Teja S Pandrangi; Safa Z Khan; Jiang Xu; Tengis S Pavlov; Pablo A Ortiz; Edward Peterson; Pamela Harding
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

7.  A truncated splice-variant of the FcεRIβ receptor subunit is critical for microtubule formation and degranulation in mast cells.

Authors:  Glenn Cruse; Michael A Beaven; Ian Ashmole; Peter Bradding; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Immunity       Date:  2013-05-02       Impact factor: 31.745

8.  Gab docking proteins in cardiovascular disease, cancer, and inflammation.

Authors:  Yoshikazu Nakaoka; Issei Komuro
Journal:  Int J Inflam       Date:  2013-01-22

9.  Gab adapter proteins as therapeutic targets for hematologic disease.

Authors:  Sheetal Verma; Tamisha Vaughan; Kevin D Bunting
Journal:  Adv Hematol       Date:  2011-12-14

10.  Shp2 activates Fyn and Ras to regulate RBL-2H3 mast cell activation following FcεRI aggregation.

Authors:  Xiaoyun Fang; Yongjiang Lang; Yuxiong Wang; Wei Mo; Huanhuan Wei; Jianhui Xie; Min Yu
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.